All-trans-retinoic acid (ATRA) plus oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carcinoma and extrahepatic metastasis: study protocol for a randomized controlled trial
Among patients with hepatocellular carcinoma (HCC), 85% of patients have an advanced disease stage at diagnosis and curative therapies cannot be performed. Prognosis has been quite poor as until recently there...
Source: Trials - Category: General Medicine Authors: Jie Shi, Juxian Sun, Chang Liu, Zongtao Chai, Nanya Wang, Hui Zhang and Shuqun Cheng Tags: Study protocol Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Eloxatin | General Medicine | Hepatocellular Carcinoma | Liver Cancer | Palliative | Study